Author:
Bilaloglu Seda,Wu Joyce,Fierro Eduardo,Sanchez Raul Delgado,Ocampo Paolo Santiago,Razavian Narges,Coudray Nicolas,Tsirigos Aristotelis
Abstract
AbstractVisual analysis of solid tissue mounted on glass slides is currently the primary method used by pathologists for determining the stage, type and subtypes of cancer. Although whole slide images are usually large (10s to 100s thousands pixels wide), an exhaustive though time-consuming assessment is necessary to reduce the risk of misdiagnosis. In an effort to address the many diagnostic challenges faced by trained experts, recent research has been focused on developing automatic prediction systems for this multi-class classification problem. Typically, complex convolutional neural network (CNN) architectures, such as Google’s Inception, are used to tackle this problem. Here, we introduce a greatly simplified CNN architecture, PathCNN, which allows for more efficient use of computational resources and better classification performance. Using this improved architecture, we trained simultaneously on whole-slide images from multiple tumor sites and corresponding non-neoplastic tissue. Dimensionality reduction analysis of the weights of the last layer of the network capture groups of images that faithfully represent the different types of cancer, highlighting at the same time differences in staining and capturing outliers, artifacts and misclassification errors. Our code is available online at:https://github.com/sedab/PathCNN.
Publisher
Cold Spring Harbor Laboratory
Reference45 articles.
1. Hughes Targeted therapy for non-small cell lung cancer: current standards and the promise of the future;Translational Lung Cancer Research,2015
2. Andrew G. Nicholson , Andrew G. Nicholson , David Gonzalez , Pallav Shah , Matthew J. Pynegar , Manjiri Deshmukh , Alexandra Rice , Sanjay Popat Refining the diagnosis and egfr status of non-small cell carcinoma in biopsy and cytologic material, using a panel of mucin staining, ttf-1, cytokeratin 5/6 and p63, and egfr mutation analysis. The Journal of Pathology, 220:S2, 2010.
3. The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
4. Michael Snyder . Genomics and Personalized Medicine: What Everyone Needs to Know. Oxford University Press, 2016.
5. Validation of interobserver agreement in lung cancer assessment: Hematoxylin-eosin diagnostic reproducibility for non–small cell lung cancer: The 2004 world health organization classification and therapeutically relevant subsets;Archives of pathology & laboratory medicine,2012
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献